Logo

NEWSBRIEF: Athersys Pockets $16.2M in Private Stock Placement

May 13, 2002

NEW YORK, May 13 - Athersys said today it has pocketed $16.2 million in a private stock placement.

 

National City Equity Partners, Greenleaf Capital Management, and the Biomedical Sciences Investment Fund of the Singapore Economic Development Board joined existing shareholders in the placement, which Athersys will use to fuel R&D in oncology, inflammation, neurobiology, and developmental biology, it said.

 

For more information, visit the company's website.

Breaking News
The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.